Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-26-018086
Filing Date
2026-04-20
Accepted
2026-04-20 16:01:14
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 7495
  Complete submission text file 0001493152-26-018086.txt   8970
Mailing Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670
Business Address 85 MEDINAT HA-YEHUDIM STREET HERZLIYA L3 4676670 972774605012
Intercure Ltd. (Issuer) CIK: 0001857030 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O, INTERCURE LTD. 85 MEDINAT HA-YEHUDIM STREET HERZLIYA Israel 4676670
Business Address
Rabinovich Alexander (Reporting) CIK: 0002081490 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40614 | Film No.: 26874984